Acta Ophthalmol 91(1):611 Martnez-Sols I et al (2019) Neuroprotective potential of Ginkgo biloba in retinal diseases
I.et al (1999)
Shortage mitigation: Temporarily filling access gaps
Methods The study was designed with one screening round (9 doses over 3 days) of DMSA in Phase 1, followed by a randomized, double-blind, placebo-controlled study of 6 additional rounds (see Figure 1)
A total of three cytosolic isoforms of MDHARs have been reported in the moss Physcomitrella patens (Lunde et al., Physcomitrella apparently lacks any chloroplastic isoform indicating that AsA reduction in the plant exclusively occurs in cytosol (Drew et al., In order to protect against the deleterious effects of ROS, the AsA pools are required to be maintained in a reduced state
Further research is needed with aging, fit, healthy subjects, measuring a variety of physiologic and metabolic endpoints to determine if the results of this case study prevail, and if so, the mechanism of any such benefits achieved